Syngene International Ltd

Syngene International Ltd

$SYNGENEHealthcare Research- Analytics & TechnologyNSEBSE

Syngene International Ltd (SYNGENE) last traded at ₹406, a market capitalisation of ₹16,399 crore, on a P/E of 55.4. Over the past 52 weeks the stock has ranged between ₹375 and ₹679. Syngene International Ltd last reported results for the quarter ended Jun 2026, with sales of ₹736 crore and net profit of ₹-9 crore. The next scheduled event is an analyst meet on 28 Aug 2026. Figures are as of 25 Aug 2026 and are not real time.

Syngene International Ltd share price and key metrics

Current price
₹406
Market cap
₹16,399 cr
Stock P/E
55.4
Book value
₹120
ROE
7.78%
ROCE
9.99%
Dividend yield
0.31%
52w high / low
679/375

Metrics as of 25 Aug 2026. Not real time.

Syngene International Ltd quarterly results

In the quarter ended Jun 2026, sales were ₹736 cr, down 15.8% from ₹875 cr a year earlier. Net profit swung to a loss of ₹9 cr.

Syngene International Ltd consolidated quarterly results, figures in ₹ crore
₹ croreSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales8919441,0188759119171,037736
Expenses646660674668711708733645
Operating profit24528434420620020930390.8
OPM %27.47%30.05%33.75%23.60%21.91%22.81%29.27%12.34%
Other income16.518.318.917.715.4-55.216.211.8
Interest13.112.415.911.613.211.912.19.6
Depreciation111109106111117114112112
Profit before tax13718124110185.228.4196-19.2
Tax %22.72%27.49%23.78%14.41%21.24%47.18%24.54%-53.12%
Net profit10613118386.767.115148-9
EPS (₹)2.643.264.552.151.670.373.67-0.22

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Syngene International Ltd annual results

Syngene International Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales2,1842,6043,1933,4893,6423,7393,600
Operating profit6787439421,0171,045921803
OPM %31%29%30%29%29%25%22%
Net profit405396464510496317221
EPS (₹)10.129.8811.5712.6912.337.865.49

TTM is the trailing twelve months to the most recent quarter.

Syngene International Ltd growth and returns

Compounded Sales Growth
10 Years
%
5 Years
11%
3 Years
5%
TTM
-3%
Compounded Profit Growth
10 Years
%
5 Years
0%
3 Years
-8%
TTM
-42%
Stock Price CAGR
10 Years
6%
5 Years
-8%
3 Years
-20%
1 Year
-40%
Return on Equity
10 Years
%
5 Years
11%
3 Years
10%
Last Year
8%

Syngene International Ltd shareholding pattern

Promoters held 52.59% at Jun 2026, broadly unchanged since Jun 2025. FIIs 11.82% and DIIs 28.01%.

Syngene International Ltd shareholding pattern by quarter, in percent
% heldSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters54.72%52.74%52.74%52.68%52.68%52.68%52.68%52.59%
FIIs20.72%20.65%19.47%16.51%16.31%14.96%13.91%11.82%
DIIs17.49%19.52%21.50%24.05%24.62%25.83%26.44%28.01%
Public6.74%6.79%5.99%6.45%6.08%6.22%6.69%7.15%
No. of shareholders1,07,3381,28,8061,25,0901,42,3101,36,0611,31,7501,35,6051,42,277

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

Upcoming Syngene International Ltd events

The next scheduled event is an analyst meet on 28 Aug 2026.

  • Analyst meetOne-on-one meeting with Entrust Family Office
  • Analyst meetParticipation in Goldman Sachs Asia Leaders Conference 2026

See the full results calendar for every Indian company reporting in the next 30 days.

Syngene International Ltd corporate filings

  • Intimation of Schedule of Investor/Analyst Meeting with Goldman Sachs Asia Leaders Conference 2026Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Syngene International has announced its participation in the Goldman Sachs Asia Leaders…

    Read the full analysis
  • Intimation of investment in Ampin C&I Power Twelve Private LimitedCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Syngene International Limited has entered into a Share Subscription and Shareholders…

    Read the full analysis
  • Intimation of Investor call schedule with Entrust Family OfficeCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Syngene International has announced an investor meeting with Entrust Family Office…

    Read the full analysis
  • Intimation of Schedule of Meeting with Analyst/Institutional Investor on August 13, 2026 and August 14, 2026.Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Syngene International has announced a schedule for meetings with analysts and…

    Read the full analysis
  • Intimation of Earnings Conference call transcript for Q1 FY2027Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Syngene International Limited has formally submitted the transcript of its Q1 FY2027…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Syngene International Ltd

Cruxal reads every Syngene International Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.